D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Price:
67 300
VND
Market Cap:
2.3T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DMC Alert
Domesco Medical Import Export Joint Stock Corp
67300
0 (0%)
| 52 Week Range |
65 800
73 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Domesco Medical Import Export Joint Stock Corp
Balance Sheet
Balance Sheet Decomposition
Domesco Medical Import Export Joint Stock Corp
Domesco Medical Import Export Joint Stock Corp
| Current Assets | 1.8T |
| Cash & Short-Term Investments | 588.9B |
| Receivables | 747.8B |
| Other Current Assets | 447.5B |
| Non-Current Assets | 174.3B |
| Long-Term Investments | 17.9B |
| PP&E | 109.3B |
| Intangibles | 45B |
| Other Non-Current Assets | 2.1B |
| Current Liabilities | 455.2B |
| Accounts Payable | 300.5B |
| Accrued Liabilities | 34.2B |
| Other Current Liabilities | 120.5B |
| Non-Current Liabilities | 413.3m |
| Other Non-Current Liabilities | 413.3m |
Balance Sheet
Domesco Medical Import Export Joint Stock Corp
Domesco Medical Import Export Joint Stock Corp
Currency: VND
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
26 583
|
28 704
|
135 164
|
92 319
|
158 731
|
79 508
|
98 367
|
0
|
0
|
114 332
|
|
| Cash |
26 583
|
28 704
|
55 128
|
72 319
|
88 731
|
79 508
|
98 367
|
0
|
0
|
59 332
|
|
| Cash Equivalents |
0
|
0
|
80 036
|
20 000
|
70 000
|
0
|
0
|
0
|
0
|
55 000
|
|
| Short-Term Investments |
30 000
|
0
|
0
|
115 000
|
270 000
|
290 000
|
260 000
|
225 000
|
405 000
|
475 000
|
|
| Total Receivables |
329 634
|
286 873
|
304 286
|
309 970
|
397 200
|
577 580
|
710 066
|
756 590
|
730 890
|
709 471
|
|
| Accounts Receivables |
320 224
|
281 066
|
285 106
|
295 362
|
377 865
|
550 932
|
695 879
|
739 994
|
714 272
|
686 787
|
|
| Other Receivables |
9 410
|
5 807
|
19 181
|
14 608
|
19 334
|
26 648
|
14 187
|
16 596
|
16 619
|
22 684
|
|
| Inventory |
312 072
|
311 931
|
277 344
|
321 656
|
248 482
|
276 012
|
226 268
|
352 004
|
410 856
|
367 933
|
|
| Other Current Assets |
14 753
|
10 202
|
3 200
|
3 984
|
4 797
|
8 591
|
3 840
|
2 784
|
4 397
|
4 728
|
|
| Total Current Assets |
713 042
|
637 711
|
719 994
|
842 930
|
1 079 211
|
1 231 692
|
1 298 542
|
1 421 755
|
1 598 608
|
1 671 464
|
|
| PP&E Net |
231 623
|
217 715
|
193 037
|
170 821
|
154 996
|
163 051
|
167 055
|
134 635
|
124 301
|
112 391
|
|
| PP&E Gross |
231 623
|
217 715
|
193 037
|
170 821
|
154 996
|
163 051
|
167 055
|
134 635
|
124 301
|
112 391
|
|
| Accumulated Depreciation |
167 522
|
201 038
|
232 210
|
259 604
|
287 193
|
314 299
|
333 433
|
372 608
|
389 675
|
406 957
|
|
| Intangible Assets |
51 888
|
51 902
|
51 456
|
49 644
|
48 397
|
47 860
|
48 076
|
45 607
|
46 530
|
45 696
|
|
| Long-Term Investments |
11 531
|
9 704
|
13 169
|
10 573
|
12 002
|
12 137
|
12 844
|
17 601
|
67 601
|
17 908
|
|
| Other Long-Term Assets |
11 689
|
15 269
|
10 368
|
10 026
|
10 868
|
10 349
|
6 536
|
2 253
|
937
|
1 707
|
|
| Total Assets |
1 019 773
N/A
|
932 300
-9%
|
988 023
+6%
|
1 083 994
+10%
|
1 305 473
+20%
|
1 465 089
+12%
|
1 533 053
+5%
|
1 621 851
+6%
|
1 837 977
+13%
|
1 849 166
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
190 361
|
142 024
|
137 616
|
120 021
|
162 271
|
216 705
|
220 083
|
206 409
|
316 963
|
279 251
|
|
| Accrued Liabilities |
48 036
|
43 373
|
30 693
|
54 465
|
113 955
|
73 933
|
37 351
|
9 975
|
11 186
|
16 142
|
|
| Short-Term Debt |
108 761
|
0
|
0
|
0
|
0
|
23 498
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
39 827
|
23 987
|
25 419
|
25 200
|
75 630
|
20 354
|
22 133
|
39 349
|
50 179
|
32 878
|
|
| Total Current Liabilities |
386 985
|
209 384
|
193 728
|
199 686
|
351 856
|
334 491
|
279 568
|
255 732
|
378 328
|
328 271
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
2 062
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2 223
|
1 070
|
977
|
675
|
812
|
1 058
|
1 216
|
88
|
139
|
382
|
|
| Total Liabilities |
391 270
N/A
|
210 454
-46%
|
194 705
-7%
|
200 361
+3%
|
352 667
+76%
|
335 549
-5%
|
280 784
-16%
|
255 820
-9%
|
378 467
+48%
|
328 652
-13%
|
|
| Equity | |||||||||||
| Common Stock |
178 093
|
267 138
|
267 138
|
347 275
|
347 275
|
347 275
|
347 275
|
347 275
|
347 275
|
347 275
|
|
| Retained Earnings |
73 787
|
124 441
|
142 577
|
169 659
|
155 571
|
228 772
|
232 635
|
159 282
|
200 076
|
183 333
|
|
| Additional Paid In Capital |
229 515
|
140 471
|
140 471
|
60 334
|
60 334
|
60 334
|
60 334
|
60 334
|
60 334
|
60 334
|
|
| Other Equity |
147 108
|
189 797
|
243 133
|
306 366
|
389 627
|
493 160
|
612 025
|
799 141
|
851 826
|
929 572
|
|
| Total Equity |
628 504
N/A
|
721 846
+15%
|
793 318
+10%
|
883 633
+11%
|
952 806
+8%
|
1 129 540
+19%
|
1 252 269
+11%
|
1 366 031
+9%
|
1 459 510
+7%
|
1 520 513
+4%
|
|
| Total Liabilities & Equity |
1 019 773
N/A
|
932 300
-9%
|
988 023
+6%
|
1 083 994
+10%
|
1 305 473
+20%
|
1 465 089
+12%
|
1 533 053
+5%
|
1 621 851
+6%
|
1 837 977
+13%
|
1 849 166
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
35
|
35
|
35
|
35
|
35
|
35
|
35
|
35
|
35
|
35
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
